Taiwan Biomaterial Co., Ltd. (TPEX:6649)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
38.85
-0.55 (-1.40%)
Jul 9, 2026, 1:30 PM CST
Market Cap1.63B +2.2%
Revenue (ttm)179.17M +23.1%
Net Income26.02M -19.3%
EPS0.61 -20.2%
Shares Out 42.00M
PE Ratio63.38
Forward PEn/a
Dividend1.00 (2.54%)
Ex-Dividend DateApr 9, 2026
Volume14,196
Open39.00
Previous Close39.40
Day's Range38.60 - 39.20
52-Week Range35.80 - 80.40
Beta0.38
Analystsn/a
Price Targetn/a
Earnings DateAug 10, 2026

About Taiwan Biomaterial

Taiwan Biomaterial Co., Ltd. engages in the development and sale of implantable medical devices in Taiwan. It provides Foamagen, a foamagen dura substitute; stroke thrombus negative pressure removal catheter system comprising suction and removal of cerebrovascular embolism blood clot for the pump system, and nickel-titanium guidewire for guiding cerebral vascular surgery; tissue repair and regeneration products for the treatment of early osteoarthritis; and CDMO. The company was founded in 1921 and is based in Zhubei, Taiwan. [Read more]

Sector Healthcare
Founded 1921
Employees 46
Stock Exchange Taipei Exchange
Ticker Symbol 6649
Full Company Profile

Financial Performance

Financial Statements